Beatrice Jacquelin is a committed scientist in HIV/AIDS research. She developed her first research skills in hemostasis and hematopoiesis from 1998 to 2004. She worked at The Scripps Research Institute, in California, USA, followed by research positions in a CNRS laboratory in Bordeaux and then at the Genopole of Evry. During these years, she developed a solid expertise in human gene regulation.
In 2004, she switched to HIV/AIDS research and joined the group of Michaela Müller-Trutwin in Françoise Barré-Sinoussi's laboratory at the Institut Pasteur, Paris. Since then, she has focused her research on the pathological mechanisms behind the abnormal T cell activation that leads to AIDS, using SIV infection models. Her research projects are now dedicated to identifying factors that influence susceptibility to HIV/SIV-induced inflammation and factors that contribute to the control of this inflammation.
In addition, Beatrice is also exploring new targets for anti-inflammatory therapies in SIV animal models, but also in HIV-infected patients. Her contribution to HIV/AIDS research is driven by her commitment to gaining crucial insights into gene regulation and developing innovative therapeutic strategies.
